Top Story

Recent ophthalmology news in review

March 17, 2018

BLOG: The big and small picture with MP3 and Cyclo G6

March 16, 2018
We recently presented results from a retrospective analysis of 26 eyes of 20 patients who underwent MP3 treatment with the Cyclo G6. Patients ranged from mild to severe…

EyeGate reports 2017 net loss of $13.2 million

March 16, 2018
EyeGate Pharmaceuticals reported a net loss of $13.2 million in 2017 compared with a net loss of $13.3 million the previous year, according to a press release. Research…

Nicox, Bausch + Lomb restructure Vyzulta financial terms

March 16, 2018
Nicox and Bausch + Lomb have agreed to new financial terms for Vyzulta, which includes an additional $20 million in potential milestone payments, according to a press…

Rocket Pharmaceuticals posts $19.6 million annual net loss

March 16, 2018
Rocket Pharmaceuticals, which recently merged with Inotek Pharmaceuticals, reported a net loss of $19.6 million, or $219.49 per share, in 2017 compared with a net loss…
More Headlines »
Original Article

Nepafenac Ophthalmic Suspension 0.3% for the Management of Ocular Pain After Photorefractive Keratectomy

Journal of Refractive Surgery, March 2018, Volume 34 Issue 3
To investigate the effect of nepafenac 0.3% in a once daily dosage regarding pain and healing after photorefractive…
More »

Optimizing Strategies for Topical Management of Glaucoma: Treatment Options and Improving Adherence

Because glaucoma typically begins by affecting the far periphery of the vision, most patients are unaware that they…
More »
Resource Centers
From OSN Europe Video
Meeting News

VIDEO: Surgeon speaks about antibiotic resistance and the need to change current practices

February 22, 2018
More »